title: Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
abstract: Seven days after bilateral 6-OHDA denervation of the nucleus accumbens locomotor activity was recorded in rats. 6-OHDA lesion strongly enhanced hypermotility induced by apomorphine (1.0 mg/kg IP) as a sign of behavioral dopaminergic supersensitivity. The potency of the classical neuroleptic haloperidol (0.03-0.25 mg/kg IP) to antagonize apomorphine-induced hypermotility was reduced in 6-OHDA-pretreated rats. The atypical neuroleptics sulpiride (5.0-20.0 mg/kg IP), thioridazine (1.0-5.25 mg/kg IP) and clozapine (0.5-2.0 mg/kg IP) and the 5-HT antagonists cyproheptadine (0.2 mg/kg IP) and ritanserin (0.01 mg/kg IP) suppressed the augmented apomorphine response in 6-OHDA-lesioned animals to the level of the apomorphine effect in controls. It is concluded that the model of denervation supersensitivity is capable of differentiating typical and atypical neuroleptics. The abolition of the 6-OHDA-induced increase of the apomorphine hypermotility by the atypical neuroleptics cannot be explained solely by postsynaptic dopamine receptor antagonism. Serotonergic mechanism may be involved in this action.
authors.affiliation: Institute of Pharmacology and Toxicology of Charité, Humboldt University, Berlin.
authors.forename: C
authors.initials: C
authors.lastname: Schremmer
authors.forename: R
authors.initials: R
authors.lastname: Morgenstern
authors.forename: H
authors.initials: H
authors.lastname: Fink
authors.forename: T
authors.initials: T
authors.lastname: Ott
mesh_terms: D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001058:Apomorphine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D003024:Clozapine / Q000494:pharmacology; D003533:Cyproheptadine / Q000494:pharmacology; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D010880:Piperidines / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000187:drug effects*; D016713:Ritanserin; D012702:Serotonin Antagonists / Q000494:pharmacology; D013469:Sulpiride / Q000494:pharmacology; D013881:Thioridazine / Q000494:pharmacology
chemical_list: D014150:Antipsychotic Agents; D010880:Piperidines; D011954:Receptors, Dopamine; D012702:Serotonin Antagonists; D016713:Ritanserin; D003533:Cyproheptadine; D013469:Sulpiride; D003024:Clozapine; D006220:Haloperidol; D001058:Apomorphine; D013881:Thioridazine